Plain-English translation of NCT03424850 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing high dose rate brachytherapy—a targeted radiation procedure where radioactive seeds are temporarily placed inside the prostate to deliver a powerful dose of radiation directly to cancer cells. Researchers want to find out which radiation dose (21, 23, or 25 units) works best and causes the fewest side effects for men with early-stage prostate cancer.
Standard prostate cancer treatments can have unwanted side effects, and doctors are looking for ways to deliver effective treatment in a single session rather than multiple sessions over weeks.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will receive a one-time brachytherapy procedure where the doctor places radioactive seeds in your prostate during an implant procedure. The entire treatment—from implant to radiation delivery—happens within a 24-hour period. You will be assigned to receive one of three radiation dose levels, and the research team will follow you over time to monitor how well the treatment works and track any side effects.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
United States